Cargando…

Feasibility of using infant testing during immunization to estimate HIV mother-to-child-transmission rates in Zambia

BACKGROUND: This study piloted the feasibility of infant testing in immunization services as a strategy for estimating MTCT rates among the population of HIV exposed infants at national and subnational levels in Zambia. METHODS: The study recruited a cross-sectional nationally representative sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Simbaya, Joseph, Funjika, Patricia, Moonga, Arthur, Mwale, John, Kankasa, Chipepo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655713/
https://www.ncbi.nlm.nih.gov/pubmed/34886792
http://dx.doi.org/10.1186/s12879-021-06892-0
_version_ 1784612128220512256
author Simbaya, Joseph
Funjika, Patricia
Moonga, Arthur
Mwale, John
Kankasa, Chipepo
author_facet Simbaya, Joseph
Funjika, Patricia
Moonga, Arthur
Mwale, John
Kankasa, Chipepo
author_sort Simbaya, Joseph
collection PubMed
description BACKGROUND: This study piloted the feasibility of infant testing in immunization services as a strategy for estimating MTCT rates among the population of HIV exposed infants at national and subnational levels in Zambia. METHODS: The study recruited a cross-sectional nationally representative sample of 8042 caregiver-baby pairs in 38 high volume immunization sites in 7 towns across 3 provinces of Zambia. All mothers who brought their children below the age of one year for immunization at the study facilities were invited to participate in the study. All consenting mothers were interviewed and blood drawn from their babies for; rapid HIV antibody test to determine exposure and DNA PCR test for samples of all HIV-exposed babies to determine HIV infection. RESULTS: Of 8042 recruited caregiver–baby pairs, 1409 (17.5%) babies were HIV-exposed. Approximately 90.2% of all mothers of HIV exposed infants reported that they attended ANC visits more than two times and facility based deliveries stood at 91.6%. Exclusive breastfeeding among HIV exposed infants reduced with increase in age of infant; it was highest at 6 weeks (82.2%) followed by 10 weeks (74.0%) and 14 weeks (58.2%). MTCT rates were relatively lower than what was reported before in subnational studies and stood at 4.7% among Penta 1 seekers, 2.8% among Penta 2 seekers, 2.1% among Penta 3 seekers and 5.0% among Measles vaccination seekers. The overall MTCT rate stood at 3.8%. About 48.1% of HIV positive babies were male compared to 51.9% females. Babies of mothers below the age of 25 years accounted for almost half (51.9%) of all HIV infected babies in the study. Reported exclusive breastfeeding among HIV positive babies was 77.8% for Penta 1 seekers, 75.0% for Penta 2 seekers and 100% for Penta 3 seekers. CONCLUSIONS: The study succeeded in estimating the MTCT rates using infant testing in immunization services, thereby demonstrating that it is feasible to use routine infant testing in immunization services as a strategy for estimating MTCT rates among the population of HIV-exposed infants in countries with high HIV burden and immunization coverage.
format Online
Article
Text
id pubmed-8655713
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86557132021-12-09 Feasibility of using infant testing during immunization to estimate HIV mother-to-child-transmission rates in Zambia Simbaya, Joseph Funjika, Patricia Moonga, Arthur Mwale, John Kankasa, Chipepo BMC Infect Dis Research Article BACKGROUND: This study piloted the feasibility of infant testing in immunization services as a strategy for estimating MTCT rates among the population of HIV exposed infants at national and subnational levels in Zambia. METHODS: The study recruited a cross-sectional nationally representative sample of 8042 caregiver-baby pairs in 38 high volume immunization sites in 7 towns across 3 provinces of Zambia. All mothers who brought their children below the age of one year for immunization at the study facilities were invited to participate in the study. All consenting mothers were interviewed and blood drawn from their babies for; rapid HIV antibody test to determine exposure and DNA PCR test for samples of all HIV-exposed babies to determine HIV infection. RESULTS: Of 8042 recruited caregiver–baby pairs, 1409 (17.5%) babies were HIV-exposed. Approximately 90.2% of all mothers of HIV exposed infants reported that they attended ANC visits more than two times and facility based deliveries stood at 91.6%. Exclusive breastfeeding among HIV exposed infants reduced with increase in age of infant; it was highest at 6 weeks (82.2%) followed by 10 weeks (74.0%) and 14 weeks (58.2%). MTCT rates were relatively lower than what was reported before in subnational studies and stood at 4.7% among Penta 1 seekers, 2.8% among Penta 2 seekers, 2.1% among Penta 3 seekers and 5.0% among Measles vaccination seekers. The overall MTCT rate stood at 3.8%. About 48.1% of HIV positive babies were male compared to 51.9% females. Babies of mothers below the age of 25 years accounted for almost half (51.9%) of all HIV infected babies in the study. Reported exclusive breastfeeding among HIV positive babies was 77.8% for Penta 1 seekers, 75.0% for Penta 2 seekers and 100% for Penta 3 seekers. CONCLUSIONS: The study succeeded in estimating the MTCT rates using infant testing in immunization services, thereby demonstrating that it is feasible to use routine infant testing in immunization services as a strategy for estimating MTCT rates among the population of HIV-exposed infants in countries with high HIV burden and immunization coverage. BioMed Central 2021-12-09 /pmc/articles/PMC8655713/ /pubmed/34886792 http://dx.doi.org/10.1186/s12879-021-06892-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Simbaya, Joseph
Funjika, Patricia
Moonga, Arthur
Mwale, John
Kankasa, Chipepo
Feasibility of using infant testing during immunization to estimate HIV mother-to-child-transmission rates in Zambia
title Feasibility of using infant testing during immunization to estimate HIV mother-to-child-transmission rates in Zambia
title_full Feasibility of using infant testing during immunization to estimate HIV mother-to-child-transmission rates in Zambia
title_fullStr Feasibility of using infant testing during immunization to estimate HIV mother-to-child-transmission rates in Zambia
title_full_unstemmed Feasibility of using infant testing during immunization to estimate HIV mother-to-child-transmission rates in Zambia
title_short Feasibility of using infant testing during immunization to estimate HIV mother-to-child-transmission rates in Zambia
title_sort feasibility of using infant testing during immunization to estimate hiv mother-to-child-transmission rates in zambia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655713/
https://www.ncbi.nlm.nih.gov/pubmed/34886792
http://dx.doi.org/10.1186/s12879-021-06892-0
work_keys_str_mv AT simbayajoseph feasibilityofusinginfanttestingduringimmunizationtoestimatehivmothertochildtransmissionratesinzambia
AT funjikapatricia feasibilityofusinginfanttestingduringimmunizationtoestimatehivmothertochildtransmissionratesinzambia
AT moongaarthur feasibilityofusinginfanttestingduringimmunizationtoestimatehivmothertochildtransmissionratesinzambia
AT mwalejohn feasibilityofusinginfanttestingduringimmunizationtoestimatehivmothertochildtransmissionratesinzambia
AT kankasachipepo feasibilityofusinginfanttestingduringimmunizationtoestimatehivmothertochildtransmissionratesinzambia